Found: 33
Select item for more details and to access through your institution.
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs).
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2675, doi. 10.3390/cancers16152675
- By:
- Publication type:
- Article
Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 4, p. 1421, doi. 10.1007/s00277-023-05599-3
- By:
- Publication type:
- Article
Blinatumomab Redirects Donor Lymphocytes against CD19 + Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 22, p. 16105, doi. 10.3390/ijms242216105
- By:
- Publication type:
- Article
One disease, two faces: clonally-related AML and MPDCP with skin involvement.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 10, p. 2969, doi. 10.1007/s00277-023-05377-1
- By:
- Publication type:
- Article
Myelodysplastic/myeloproliferative neoplasm with neutrophilia (atypical chronic myeloid leukemia—aCML).
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 7, p. 1163, doi. 10.1002/ajh.26817
- By:
- Publication type:
- Article
The NPM1 mutant defines AML irrespective of blast count.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 7, p. E187, doi. 10.1002/ajh.26946
- By:
- Publication type:
- Article
NPM1‐mutated AML with starry sky pattern.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 1, p. 8, doi. 10.1111/bjh.18808
- By:
- Publication type:
- Article
Mutant NPM1: Nuclear export and the mechanism of leukemogenesis.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 550, doi. 10.1002/ajh.26862
- By:
- Publication type:
- Article
AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 992, doi. 10.1002/cncr.34608
- By:
- Publication type:
- Article
Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 481, doi. 10.1002/ajh.26812
- By:
- Publication type:
- Article
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3- d ]pyrimidin-4(3 H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 11, p. 2295, doi. 10.3390/pharmaceutics14112295
- By:
- Publication type:
- Article
SiCoDEA: A Simple, Fast and Complete App for Analyzing the Effect of Individual Drugs and Their Combinations.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/biom12070904
- By:
- Publication type:
- Article
Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first‐line systemic treatment or best supportive care: A multicenter international study.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 58, doi. 10.1111/ejh.13769
- By:
- Publication type:
- Article
Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 3012, doi. 10.3390/cancers14123012
- By:
- Publication type:
- Article
Poster: AML-347: A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-Center Study of FLT3-Mutated AML Patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitor Administration in Real-Life Clinical Practice.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S210, doi. 10.1016/S2152-2650(21)01316-1
- By:
- Publication type:
- Article
AML-347: A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-Center Study of FLT3-Mutated AML Patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitor Administration in Real-Life Clinical Practice.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S307, doi. 10.1016/S2152-2650(21)01729-8
- By:
- Publication type:
- Article
A Curious Novel Combination of Nucleophosmin (NPM1) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of NPM1 in Acute Myeloid Leukemia (AML).
- Published in:
- Genes, 2021, v. 12, n. 9, p. 1426, doi. 10.3390/genes12091426
- By:
- Publication type:
- Article
IDH1/IDH2 Inhibition in Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.639387
- By:
- Publication type:
- Article
CD123 Is Consistently Expressed on NPM1 -Mutated AML Cells.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 496, doi. 10.3390/cancers13030496
- By:
- Publication type:
- Article
ARPIR: automatic RNA-Seq pipelines with interactive report.
- Published in:
- BMC Bioinformatics, 2020, v. 21, n. 19, p. 1, doi. 10.1186/s12859-020-03846-2
- By:
- Publication type:
- Article
Fibrin-associated large B-cell lymphoma: first case report within a cerebral artery aneurysm and literature review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Getting away with phase transition: NPM1-mutated bone myeloid sarcoma mimicking Ewing sarcoma.
- Published in:
- 2019
- By:
- Publication type:
- case study
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 12, p. 1, doi. 10.1038/s41419-018-1185-6
- By:
- Publication type:
- Article
Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates.
- Published in:
- 2018
- By:
- Publication type:
- journal article
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature.
- Published in:
- Clinical Case Reports, 2016, v. 4, n. 12, p. 1138, doi. 10.1002/ccr3.723
- By:
- Publication type:
- Article
Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 3, p. 305, doi. 10.1111/bjh.13409
- By:
- Publication type:
- Article
Identification of novel DNA-damage tolerance genes reveals regulation of translesion DNA synthesis by nucleophosmin.
- Published in:
- Nature Communications, 2014, v. 5, n. 11, p. 5437, doi. 10.1038/ncomms6437
- By:
- Publication type:
- Article
Immunophenotypic and molecular features of 'cuplike' acute myeloid leukemias.
- Published in:
- European Journal of Haematology, 2014, v. 92, n. 2, p. 121, doi. 10.1111/ejh.12217
- By:
- Publication type:
- Article
IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas.
- Published in:
- Histopathology, 2012, v. 61, n. 5, p. 930, doi. 10.1111/j.1365-2559.2012.04289.x
- By:
- Publication type:
- Article
Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes.
- Published in:
- Genes, Chromosomes & Cancer, 2010, v. 49, n. 11, p. 1014, doi. 10.1002/gcc.20810
- By:
- Publication type:
- Article
Transformation by Retroviral Vectors of Bone Marrow-Derived Mesenchymal Cells Induces Mitochondria-Dependent cAMP-Sensitive Reactive Oxygen Species Production.
- Published in:
- Stem Cells, 2008, v. 26, n. 11, p. 2843, doi. 10.1634/stemcells.2007-0885
- By:
- Publication type:
- Article
Editorial. The involvement of the proto-oncogene p120 c-Cbl and ZAP-70 in CD2-mediated T cell activation.
- Published in:
- International Immunology, 2001, v. 13, n. 1, p. 13, doi. 10.1093/intimm/13.1.13
- By:
- Publication type:
- Article
Molecular and cytogenetic remission in a case of subtype M4E acute myelogenous leukemia with minimal monochemotherapy: high sensitivity or spontaneous remission?
- Published in:
- European Journal of Haematology, 2000, v. 65, n. 3, p. 203, doi. 10.1034/j.1600-0609.2000.9C220.x
- By:
- Publication type:
- Article